9715 KEY WEST AVENUE, ROCKVILLE, MD
To Announce Third Quarter 2025 Financial Results and Host Conference Call on November 4, 2025
Amended material disclosure
Announces Second Quarter 2025 Financial Results
Changes in Board, Management or Compensation
Completes Acquisition of Sage Therapeutics
To Announce Second Quarter 2025 Financial Results and Host Conference Call and Webcast on August 5, 2025
News
Acquisition of Sage Therapeutics, Inc.
Q2
Q1
FY 2023
Q3
Tender Offer Statement by Third Party
Tender Offer Statement by Issuer
Registration Statement for Securities to be Offered to Employees
Additional Proxy Materials
Definitive Proxy Statement
Statement of Changes in Beneficial Ownership
Notice of Proposed Sale of Securities
Amended Tender Offer Statement by Third Party
S-8 POS